Live feed08:30:00·98dSave storyNEWSReleasevia QuantisnowAs Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for EbolaByQuantisnow·Wall Street's wire, on your screen.NNVCNanoViricides Inc.Health Care